Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RENal Outcomes of Rivaroxaban Compared With Warfarin in Asian patienTs With nOn-valvular atRial Fibrillation: a Nationwide Population-based Study

NCT05022758 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05022758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05022758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RENal Outcomes of Rivaroxaban Compared With Warfarin in Asian patienTs With nOn-valvular atRial Fibrillation: a Nationwide Population-based Study
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
October 6, 2021
Completion date
October 24, 2022
Enrollment
45,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-valvular atrial fibrillation (nvaf)